loading page

Reinfection with cytomegalovirus during pregnancy: a prospective cohort study in Canada
  • +9
  • Juliette ST-GEORGES,
  • Safari Joseph BALEGAMIRE,
  • Ariane LAROUCHE,
  • Suresh B. Boppana,
  • Christian Renaud,
  • Benoît MÂSSE,
  • Yves GIGUERE,
  • Jean-Claude FOREST,
  • Valerie LAMARRE,
  • François AUDIBERT,
  • Soren GANTT,
  • Isabelle Boucoiran
Juliette ST-GEORGES
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Safari Joseph BALEGAMIRE
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Ariane LAROUCHE
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Suresh B. Boppana
The University of Alabama at Birmingham Department of Pediatrics
Author Profile
Christian Renaud
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Benoît MÂSSE
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Yves GIGUERE
Centre Hospitalier Universitaire de Quebec-Universite Laval
Author Profile
Jean-Claude FOREST
Centre Hospitalier Universitaire de Quebec-Universite Laval
Author Profile
Valerie LAMARRE
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
François AUDIBERT
Universite de Montreal
Author Profile
Soren GANTT
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine
Author Profile
Isabelle Boucoiran
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine

Corresponding Author:[email protected]

Author Profile

Abstract

Background: Congenital cytomegalovirus infections (cCMV) are an important cause of childhood neurodevelopmental deficits. Most cCMV are the result of maternal non-primary infections during pregnancy, which can be due to reactivation or reinfection. Objective: To identify the rate of CMV reinfection during pregnancy and its risk factors. Study Design: We performed a secondary analysis of CMV seropositive participants from two prospective cohort studies in Quebec, Canada. Antibody responses to four strain-specific CMV epitopes located in glycoproteins B and H were measured by enzyme-linked immunosorbent assay. CMV reinfection was defined as the appearance of an antibody response to a new epitope in the third compared to the first trimester. Risk factors for reinfection were assessed. Results: Among 1614 participants, CMV reinfection was identified in 2.7% of participants, representing an incidence of 54.99 per 1000 person-years at risk (95% confidence interval 39.95-73.82). Age, marital status, household income, continent of birth or ethnicity were not associated with reinfection during pregnancy. Conclusions: The incidence of CMV reinfection during pregnancy is like what has been reported for primary infection in Quebec. A greater understanding of the patterns of reinfection is needed to inform strategies to reduce the burden of disease from cCMV.
17 Nov 2024Submitted to Journal of Medical Virology
18 Nov 2024Submission Checks Completed
18 Nov 2024Assigned to Editor
18 Nov 2024Review(s) Completed, Editorial Evaluation Pending
19 Nov 2024Reviewer(s) Assigned